Epidemiology  ||| S:0 E:13 ||| NNP
of  ||| S:13 E:16 ||| IN
rosacea ||| S:16 E:23 ||| NNS
:  ||| S:23 E:25 ||| :
updated  ||| S:25 E:33 ||| VBN
data  ||| S:33 E:38 ||| NNS
The  ||| S:38 E:42 ||| DT
epidemiological  ||| S:42 E:58 ||| JJ
data  ||| S:58 E:63 ||| NNS
on  ||| S:63 E:66 ||| IN
rosacea  ||| S:66 E:74 ||| NNS
remain  ||| S:74 E:81 ||| VBP
fragmentary  ||| S:81 E:93 ||| VBN
and  ||| S:93 E:97 ||| CC
the  ||| S:97 E:101 ||| DT
methodological  ||| S:101 E:116 ||| JJ
quality  ||| S:116 E:124 ||| NN
debatable ||| S:124 E:133 ||| NN
.  ||| S:133 E:135 ||| .
Rosacea  ||| S:135 E:143 ||| NNP
affects  ||| S:143 E:151 ||| VBZ
mainly  ||| S:151 E:158 ||| RB
adults  ||| S:158 E:165 ||| NNS
around  ||| S:165 E:172 ||| IN
the  ||| S:172 E:176 ||| DT
age  ||| S:176 E:180 ||| NN
of  ||| S:180 E:183 ||| IN
30  ||| S:183 E:186 ||| CD
years  ||| S:186 E:192 ||| NNS
and  ||| S:192 E:196 ||| CC
classically  ||| S:196 E:208 ||| JJ
predominates  ||| S:208 E:221 ||| NN
in  ||| S:221 E:224 ||| IN
females ||| S:224 E:231 ||| NNS
.  ||| S:231 E:233 ||| .
Recent  ||| S:233 E:240 ||| JJ
Estonian  ||| S:240 E:249 ||| JJ
and  ||| S:249 E:253 ||| CC
Irish  ||| S:253 E:259 ||| JJ
studies  ||| S:259 E:267 ||| NNS
suggest  ||| S:267 E:275 ||| VBP
that  ||| S:275 E:280 ||| IN
the  ||| S:280 E:284 ||| DT
female  ||| S:284 E:291 ||| JJ
predominance  ||| S:291 E:304 ||| NN
may  ||| S:304 E:308 ||| MD
not  ||| S:308 E:312 ||| RB
be  ||| S:312 E:315 ||| VB
as  ||| S:315 E:318 ||| IN
high  ||| S:318 E:323 ||| JJ
as  ||| S:323 E:326 ||| IN
previously  ||| S:326 E:337 ||| RB
believed ||| S:337 E:345 ||| VBN
.  ||| S:345 E:347 ||| .
However ||| S:347 E:354 ||| RB
,  ||| S:354 E:356 ||| ,
prevalence  ||| S:356 E:367 ||| NN
does  ||| S:367 E:372 ||| VBZ
increase  ||| S:372 E:381 ||| NN
with  ||| S:381 E:386 ||| IN
age ||| S:386 E:389 ||| NN
.  ||| S:389 E:391 ||| .
The  ||| S:391 E:395 ||| DT
prevalence  ||| S:395 E:406 ||| JJ
statistics  ||| S:406 E:417 ||| NNS
published  ||| S:417 E:427 ||| VBN
in  ||| S:427 E:430 ||| IN
Europe  ||| S:430 E:437 ||| NNP
and  ||| S:437 E:441 ||| CC
the  ||| S:441 E:445 ||| DT
United  ||| S:445 E:452 ||| NNP
States  ||| S:452 E:459 ||| NNPS
are  ||| S:459 E:463 ||| VBP
highly  ||| S:463 E:470 ||| RB
variable ||| S:470 E:478 ||| JJ
,  ||| S:478 E:480 ||| ,
ranging  ||| S:480 E:488 ||| VBG
from  ||| S:488 E:493 ||| IN
less  ||| S:493 E:498 ||| JJR
than  ||| S:498 E:503 ||| IN
1 ||| S:503 E:504 ||| CD
%  ||| S:504 E:506 ||| NN
to  ||| S:506 E:509 ||| TO
more  ||| S:509 E:514 ||| JJR
than  ||| S:514 E:519 ||| IN
20 ||| S:519 E:521 ||| CD
%  ||| S:521 E:523 ||| NN
of  ||| S:523 E:526 ||| IN
the  ||| S:526 E:530 ||| DT
adult  ||| S:530 E:536 ||| NN
population ||| S:536 E:546 ||| NN
;  ||| S:546 E:548 ||| :
actually ||| S:548 E:556 ||| RB
,  ||| S:556 E:558 ||| ,
the  ||| S:558 E:562 ||| DT
methods  ||| S:562 E:570 ||| NNS
used  ||| S:570 E:575 ||| VBN
and  ||| S:575 E:579 ||| CC
the  ||| S:579 E:583 ||| DT
populations  ||| S:583 E:595 ||| JJ
studied  ||| S:595 E:603 ||| NNS
vary  ||| S:603 E:608 ||| VBP
greatly  ||| S:608 E:616 ||| RB
from  ||| S:616 E:621 ||| IN
one  ||| S:621 E:625 ||| CD
study  ||| S:625 E:631 ||| NN
to  ||| S:631 E:634 ||| TO
another ||| S:634 E:641 ||| DT
;  ||| S:641 E:643 ||| :
consequently ||| S:643 E:655 ||| RB
,  ||| S:655 E:657 ||| ,
they  ||| S:657 E:662 ||| PRP
cannot  ||| S:662 E:669 ||| RB
be  ||| S:669 E:672 ||| VB
compared ||| S:672 E:680 ||| VBN
.  ||| S:680 E:682 ||| .
A  ||| S:682 E:684 ||| DT
family  ||| S:684 E:691 ||| NN
history  ||| S:691 E:699 ||| NN
of  ||| S:699 E:702 ||| IN
the  ||| S:702 E:706 ||| DT
disease  ||| S:706 E:714 ||| NN
is  ||| S:714 E:717 ||| VBZ
a  ||| S:717 E:719 ||| DT
risk  ||| S:719 E:724 ||| NN
factor ||| S:724 E:730 ||| NN
,  ||| S:730 E:732 ||| ,
as  ||| S:732 E:735 ||| RB
is  ||| S:735 E:738 ||| VBZ
the  ||| S:738 E:742 ||| DT
very  ||| S:742 E:747 ||| RB
light  ||| S:747 E:753 ||| JJ
skin  ||| S:753 E:758 ||| NN
phototype  ||| S:758 E:768 ||| NNS
( ||| S:768 E:769 ||| -LRB-
Celtic  ||| S:769 E:776 ||| NNP
skin  ||| S:776 E:781 ||| NN
type ||| S:781 E:785 ||| NN
) ||| S:785 E:786 ||| -RRB-
.  ||| S:786 E:788 ||| .
Alcohol  ||| S:788 E:796 ||| NNP
and  ||| S:796 E:800 ||| CC
coffee ||| S:800 E:806 ||| NN
,  ||| S:806 E:808 ||| ,
classically  ||| S:808 E:820 ||| VBD
blamed ||| S:820 E:826 ||| VBN
,  ||| S:826 E:828 ||| ,
are  ||| S:828 E:832 ||| VBP
not  ||| S:832 E:836 ||| RB
risk  ||| S:836 E:841 ||| VB
factors ||| S:841 E:848 ||| NNS
;  ||| S:848 E:850 ||| :
however ||| S:850 E:857 ||| RB
,  ||| S:857 E:859 ||| ,
tobacco  ||| S:859 E:867 ||| NN
may  ||| S:867 E:871 ||| MD
have  ||| S:871 E:876 ||| VB
a  ||| S:876 E:878 ||| DT
protective  ||| S:878 E:889 ||| JJ
effect ||| S:889 E:895 ||| NN
.  ||| S:895 E:897 ||| .
New  ||| S:897 E:901 ||| JJ
studies  ||| S:901 E:909 ||| NNS
are  ||| S:909 E:913 ||| VBP
undoubtedly  ||| S:913 E:925 ||| RB
necessary ||| S:925 E:934 ||| JJ
:  ||| S:934 E:936 ||| :
they  ||| S:936 E:941 ||| PRP
should  ||| S:941 E:948 ||| MD
use  ||| S:948 E:952 ||| VB
the  ||| S:952 E:956 ||| DT
diagnostic  ||| S:956 E:967 ||| JJ
and  ||| S:967 E:971 ||| CC
severity  ||| S:971 E:980 ||| NN
criteria  ||| S:980 E:989 ||| NNS
established  ||| S:989 E:1001 ||| VBN
in  ||| S:1001 E:1004 ||| IN
2002  ||| S:1004 E:1009 ||| CD
and  ||| S:1009 E:1013 ||| CC
2004 ||| S:1013 E:1017 ||| CD
.  ||| S:1017 E:1019 ||| .
Rosacea  ||| S:1019 E:1027 ||| NNP
has  ||| S:1027 E:1031 ||| VBZ
a  ||| S:1031 E:1033 ||| DT
strong  ||| S:1033 E:1040 ||| JJ
impact  ||| S:1040 E:1047 ||| NN
on  ||| S:1047 E:1050 ||| IN
quality  ||| S:1050 E:1058 ||| NN
of  ||| S:1058 E:1061 ||| IN
life  ||| S:1061 E:1066 ||| NN
and  ||| S:1066 E:1070 ||| CC
can  ||| S:1070 E:1074 ||| MD
be  ||| S:1074 E:1077 ||| VB
associated  ||| S:1077 E:1088 ||| VBN
with  ||| S:1088 E:1093 ||| IN
depressive  ||| S:1093 E:1104 ||| JJ
symptoms ||| S:1104 E:1112 ||| NNS
.  ||| S:1112 E:1114 ||| .
A  ||| S:1114 E:1116 ||| DT
specific  ||| S:1116 E:1125 ||| JJ
quality-of-life  ||| S:1125 E:1141 ||| JJ
scale ||| S:1141 E:1146 ||| NN
,  ||| S:1146 E:1148 ||| ,
the  ||| S:1148 E:1152 ||| DT
RosaQol ||| S:1152 E:1159 ||| JJ
,  ||| S:1159 E:1161 ||| ,
has  ||| S:1161 E:1165 ||| VBZ
been  ||| S:1165 E:1170 ||| VBN
established  ||| S:1170 E:1182 ||| VBN
and  ||| S:1182 E:1186 ||| CC
validated  ||| S:1186 E:1196 ||| NN
in  ||| S:1196 E:1199 ||| IN
the  ||| S:1199 E:1203 ||| DT
United  ||| S:1203 E:1210 ||| NNP
States ||| S:1210 E:1216 ||| NNPS
,  ||| S:1216 E:1218 ||| ,
by  ||| S:1218 E:1221 ||| IN
the  ||| S:1221 E:1225 ||| DT
same  ||| S:1225 E:1230 ||| JJ
group  ||| S:1230 E:1236 ||| NN
that  ||| S:1236 E:1241 ||| IN
elaborated  ||| S:1241 E:1252 ||| VBG
the  ||| S:1252 E:1256 ||| DT
Skindex  ||| S:1256 E:1264 ||| JJ
scale ||| S:1264 E:1269 ||| NN
.  ||| S:1269 E:1271 ||| .
Translations  ||| S:1271 E:1284 ||| NNS
of  ||| S:1284 E:1287 ||| IN
this  ||| S:1287 E:1292 ||| DT
scale  ||| S:1292 E:1298 ||| NN
into  ||| S:1298 E:1303 ||| IN
French ||| S:1303 E:1309 ||| JJ
,  ||| S:1309 E:1311 ||| ,
Italian ||| S:1311 E:1318 ||| JJ
,  ||| S:1318 E:1320 ||| ,
German ||| S:1320 E:1326 ||| NNP
,  ||| S:1326 E:1328 ||| ,
and  ||| S:1328 E:1332 ||| CC
Spanish  ||| S:1332 E:1340 ||| NNP
have  ||| S:1340 E:1345 ||| VBP
been  ||| S:1345 E:1350 ||| VBN
validated ||| S:1350 E:1359 ||| NN
,  ||| S:1359 E:1361 ||| ,
which  ||| S:1361 E:1367 ||| WDT
may  ||| S:1367 E:1371 ||| MD
allow  ||| S:1371 E:1377 ||| VB
future  ||| S:1377 E:1384 ||| JJ
intercultural  ||| S:1384 E:1398 ||| JJ
comparisons ||| S:1398 E:1409 ||| NNS
.  ||| S:1409 E:1411 ||| .
